Epitomee Medical Ltd (TLV: EPIT)

Epitomee Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	10	10	-
Gross Profit	10	10	-
Selling, General & Admin	3.39	2.79	3.28
Research & Development	5.88	6.8	7.79
Operating Expenses	9.27	9.58	11.07
Operating Income	0.73	0.42	-11.07
Interest Expense	-0	-0.06	-
Interest & Investment Income	1.38	1.6	0.48
Currency Exchange Gain (Loss)	-0.46	-0.46	-4.9
Other Non Operating Income (Expenses)	-0.01	-0.01	0.1
EBT Excluding Unusual Items	1.64	1.5	-15.39
Asset Writedown	-7.68	-7.18	-
Pretax Income	-6.04	-5.68	-15.39
Net Income	-6.04	-5.68	-15.39
Net Income to Common	-6.04	-5.68	-15.39
Shares Outstanding (Basic)	30	30	29
Shares Outstanding (Diluted)	30	30	29
Shares Change (YoY)	0.73%	0.70%	-
EPS (Basic)	-0.20	-0.19	-0.52
EPS (Diluted)	-0.20	-0.19	-0.52
Free Cash Flow	-10.94	-12	-13.12
Free Cash Flow Per Share	-0.37	-0.40	-0.45
Gross Margin	100.00%	100.00%	-
Operating Margin	7.30%	4.16%	-
Profit Margin	-60.35%	-56.82%	-
Free Cash Flow Margin	-109.35%	-119.96%	-
EBITDA	0.81	0.63	-11.01
EBITDA Margin	8.10%	6.30%	-
D&A For EBITDA	0.08	0.21	0.06
EBIT	0.73	0.42	-11.07
EBIT Margin	7.30%	4.16%	-

Source: S&P Capital IQ. Standard template. Financial Sources.